Cargando…

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model

BACKGROUND: Osteosarcoma is the most common primary malignant bone tumor with a 5 year survival rate of up to 70%. However, patients with metastatic disease have still a very poor prognosis. Osteosarcoma metastasis models are essential to develop novel treatment strategies for advanced disease. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayr, Lisa, Pirker, Christine, Lötsch, Daniela, Van Schoonhoven, Sushilla, Windhager, Reinhard, Englinger, Bernhard, Berger, Walter, Kubista, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768389/ https://www.ncbi.nlm.nih.gov/pubmed/29371972 http://dx.doi.org/10.18632/oncotarget.23125

Ejemplares similares

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance
por: Sevelda, Florian, et al.
Publicado: (2015)

Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
por: Kubista, Bernd, et al.
Publicado: (2017)

Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells
por: Kryeziu, Kushtrim, et al.
Publicado: (2016)

Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression
por: Englinger, Bernhard, et al.
Publicado: (2016)

Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation
por: Mathieu, Véronique, et al.
Publicado: (2012)

Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins
por: Heilos, Daniela, et al.
Publicado: (2018)

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
por: Englinger, Bernhard, et al.
Publicado: (2017)

Another step toward DNA selective targeting: Ni(II) and Cu(II) complexes of a Schiff base ligand able to bind gene promoter G-quadruplexes
por: Terenzi, Alessio, et al.
Publicado: (2016)

Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling
por: Miklos, Walter, et al.
Publicado: (2016)

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance
por: Englinger, B, et al.
Publicado: (2017)

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2022)

The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study
por: Heilos, Daniela, et al.
Publicado: (2017)

Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature
por: Pirker-Frühauf, Ulrike Michaela, et al.
Publicado: (2013)

Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness
por: Gabler, Lisa, et al.
Publicado: (2022)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

Modern cemented total knee arthroplasty design shows a higher incidence of radiolucent lines compared to its predecessor
por: Staats, Kevin, et al.
Publicado: (2018)

Total Hip Arthroplasty Using Imageless Computer-Assisted Navigation—2-Year Follow-Up of a Prospective Randomized Study
por: Lass, Richard, et al.
Publicado: (2020)

Bcl-2 correlates with localization but not outcome in human osteosarcoma
por: TRIEB, KLEMENS, et al.
Publicado: (2013)

Early Results of a New Rotating Hinge Knee Implant
por: Giurea, Alexander, et al.
Publicado: (2014)

Molecular mechanisms of chemoresistance in osteosarcoma (Review)
por: HE, HONGTAO, et al.
Publicado: (2014)

ETMR-12. Novel cell models of CNS tumors with BCOR fusion or internal tandem duplication suggest FGFR and PDGFR as promising therapy targets
por: Kirchhofer, Dominik, et al.
Publicado: (2022)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Targeting fibroblast growth factor receptors to combat aggressive ependymoma
por: Lötsch, Daniela, et al.
Publicado: (2021)

Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolism
por: Terenzi, Alessio, et al.
Publicado: (2021)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
por: Gao, Yan, et al.
Publicado: (2015)

Distal femoral reconstruction following failed total knee arthroplasty is accompanied with risk for complication and reduced joint function
por: Vertesich, Klemens, et al.
Publicado: (2019)

A comparative study of intraoperative frozen section and alpha defensin lateral flow test in the diagnosis of periprosthetic joint infection
por: Sigmund, Irene K, et al.
Publicado: (2019)

Inferior performance of established and novel serum inflammatory markers in diagnosing periprosthetic joint infections
por: Sigmund, Irene Katharina, et al.
Publicado: (2020)

Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model
por: Robl, Bernhard, et al.
Publicado: (2016)

ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
por: Li, Hongyu, et al.
Publicado: (2021)

Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

High Revision Rates of a Cementless Beta-Titanium Alloy Stem with Contamination-Free Roughened Surface in Primary Total Hip Arthroplasty
por: Stenicka, Sandra, et al.
Publicado: (2020)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
por: Li, Lan Ying, et al.
Publicado: (2019)

Galectin-3 Induces a Pro-degradative/inflammatory Gene Signature in Human Chondrocytes, Teaming Up with Galectin-1 in Osteoarthritis Pathogenesis
por: Weinmann, Daniela, et al.
Publicado: (2016)

Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients
por: Guntner, Armin Sebastian, et al.
Publicado: (2020)

Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy
por: Meng, Chenyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8h8ehrsvsjfeo4dagfgjoessru